Economic, Clinical and Quality of Life Assessment in Patients on Antiretroviral Therapy

PHASE4CompletedINTERVENTIONAL
Enrollment

68

Participants

Timeline

Start Date

November 30, 2012

Primary Completion Date

August 31, 2014

Study Completion Date

August 31, 2014

Conditions
HIV
Interventions
DRUG

Tenofovir

tenofovir 300 mg+ emtricitabine 200 mg + efavirenz 600 mg, once daily, for one year

DRUG

Zidovudine

zidovudine 300 mg + lamivudine 150 mg + nevirapine 200 mg , once daily, for a year

Trial Locations (1)

632004

Christian Medical College, Vellore

All Listed Sponsors
collaborator

Christian Medical College, Vellore, India

OTHER

lead

Tufts University

OTHER

NCT01694017 - Economic, Clinical and Quality of Life Assessment in Patients on Antiretroviral Therapy | Biotech Hunter | Biotech Hunter